{"id":"https://openalex.org/W4410804635","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e13136","title":"Sacituzumab govitecan initial dose reduction in Polish patients with metastatic triple-negative breast cancer: Impact on efficacy and safety.","display_name":"Sacituzumab govitecan initial dose reduction in Polish patients with metastatic triple-negative breast cancer: Impact on efficacy and safety.","publication_year":2025,"publication_date":"2025-05-28","ids":{"openalex":"https://openalex.org/W4410804635","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e13136"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2025.43.16_suppl.e13136","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e13136","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e13136","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062991995","display_name":"Miros\u0142awa P\u00fcsk\u00fcll\u00fco\u011flu","orcid":"https://orcid.org/0000-0002-2647-9625","observed_orcids":["https://orcid.org/0000-0002-2647-9625"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Miroslawa Puskulluoglu","raw_affiliation_strings":["Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060883938","display_name":"Anna Polakiewicz-Gilowska","orcid":"https://orcid.org/0000-0002-2175-7067","observed_orcids":["https://orcid.org/0000-0002-2175-7067"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Polakiewicz-Gilowska","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050233659","display_name":"Manuela Las\u2010Jankowska","orcid":"https://orcid.org/0000-0002-3970-0368","observed_orcids":["https://orcid.org/0000-0002-3970-0368"]},"institutions":[{"id":"https://openalex.org/I4210137953","display_name":"Centrum Onkologii","ror":"https://ror.org/03vzf8p77","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210137953"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Manuela Las-Jankowska","raw_affiliation_strings":["Department of Clinical Oncology, Oncology Center - Prof Franciszek Lukaszczyk Memorial Hospital, Bydgoszcz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Oncology Center - Prof Franciszek Lukaszczyk Memorial Hospital, Bydgoszcz, Poland","institution_ids":["https://openalex.org/I4210137953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001520565","display_name":"Renata Pacholczak\u2010Madej","orcid":"https://orcid.org/0000-0002-6535-4841","observed_orcids":["https://orcid.org/0000-0002-6535-4841"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Renata Pacholczak-Madej","raw_affiliation_strings":["Department of Gynecological Oncology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecological Oncology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094257198","display_name":"Paulina Kilian-Van Miegem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137953","display_name":"Centrum Onkologii","ror":"https://ror.org/03vzf8p77","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210137953"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Paulina Kilian-Van Miegem","raw_affiliation_strings":["Chemotherapy Outpatient Clinic, Oncology Center Prof. F. \u0141ukaszczyk in Bydgoszcz, Bydgoszcz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Outpatient Clinic, Oncology Center Prof. F. \u0141ukaszczyk in Bydgoszcz, Bydgoszcz, Poland","institution_ids":["https://openalex.org/I4210137953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033050936","display_name":"Marek Ziobro","orcid":"https://orcid.org/0000-0002-6870-9492","observed_orcids":["https://orcid.org/0000-0002-6870-9492"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marek Ziobro","raw_affiliation_strings":["Department of Clinical Oncology, The Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, The Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023706702","display_name":"Micha\u0142 Jarz\u0105b","orcid":"https://orcid.org/0000-0002-2642-9724","observed_orcids":["https://orcid.org/0000-0002-2642-9724"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Michal Jarzab","raw_affiliation_strings":["Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036264969","display_name":"Aleksandra \u0141acko","orcid":"https://orcid.org/0000-0003-2014-993X","observed_orcids":["https://orcid.org/0000-0003-2014-993X"]},"institutions":[{"id":"https://openalex.org/I385303915","display_name":"Wroclaw Medical University","ror":"https://ror.org/01qpw1b93","country_code":"PL","type":"education","lineage":["https://openalex.org/I385303915"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Aleksandra \u0141acko","raw_affiliation_strings":["Wroclaw University of Medicine; Breast Unit, Lower Silesian Oncology Centre, Wroc\u0142aw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wroclaw University of Medicine; Breast Unit, Lower Silesian Oncology Centre, Wroc\u0142aw, Poland","institution_ids":["https://openalex.org/I385303915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035640011","display_name":"Ma\u0142gorzata Pieni\u0105\u017cek","orcid":"https://orcid.org/0000-0001-5864-0877","observed_orcids":["https://orcid.org/0000-0001-5864-0877"]},"institutions":[{"id":"https://openalex.org/I385303915","display_name":"Wroclaw Medical University","ror":"https://ror.org/01qpw1b93","country_code":"PL","type":"education","lineage":["https://openalex.org/I385303915"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Ma\u0142gorzata Pieni\u0105\u017cek","raw_affiliation_strings":["Department of Oncology, Wroc\u0142aw Medical University; Lower Silesian Comprehensive Cancer Center, Wroc\u0142aw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Wroc\u0142aw Medical University; Lower Silesian Comprehensive Cancer Center, Wroc\u0142aw, Poland","institution_ids":["https://openalex.org/I385303915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10149163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"16_suppl","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8657000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8657000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.03889999911189079,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.02329999953508377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sacituzumab-govitecan","display_name":"sacituzumab govitecan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/metastatic-triple-negative-breast-cancer","display_name":"metastatic triple-negative breast cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.3630000054836273},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7919999957084656},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7670000195503235},{"id":"https://openalex.org/keywords/g-csf-prophylaxis","display_name":"G-CSF prophylaxis","score":0.734000027179718},{"id":"https://openalex.org/keywords/pharmaceutical-waste","display_name":"pharmaceutical waste","score":0.6000000238418579},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.36800000071525574},{"id":"https://openalex.org/keywords/real-world-clinical-practice","display_name":"real-world clinical practice","score":0.5270000100135803},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9206645488739014},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7130773663520813},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5727092027664185},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5478744506835938},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5287953019142151},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5012376308441162},{"id":"https://openalex.org/C2992734768","wikidata":"https://www.wikidata.org/wiki/Q48964","display_name":"Triple negative","level":4,"score":0.47766169905662537},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4244788587093353}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2025.43.16_suppl.e13136","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e13136","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e13136","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064898491","https://openalex.org/W2592049401","https://openalex.org/W2387231244","https://openalex.org/W2117189145","https://openalex.org/W2037317309","https://openalex.org/W2156193942","https://openalex.org/W2892677547","https://openalex.org/W3203000403","https://openalex.org/W3151231688","https://openalex.org/W3203106735"],"abstract_inverted_index":{"e13136":[0],"Background:":[1],"Sacituzumab":[2],"govitecan":[3],"(SG)":[4],"is":[5,95],"approved":[6],"for":[7,152,345],"the":[8,16,45,66,77,87,111,161,170,180,223,235,283,331,343],"treatment":[9,18,139],"of":[10,25,34,68,113,183,218,261,275,282],"metastatic":[11],"triple-negative":[12],"breast":[13],"cancer":[14],"in":[15,123,127,251,270],"\u22652":[17,245,338],"line":[19],"setting,":[20],"with":[21,44,52,169,214,318],"a":[22,35,53,73,215],"standard":[23],"dosage":[24],"10":[26,46],"mg/kg":[27,47],"IV":[28],"on":[29,118,186,322],"Days":[30],"1":[31],"and":[32,121,143,164,190,234,246,256,366],"8":[33,50],"21-day":[36],"cycle.":[37],"Clinical":[38],"trials":[39],"have":[40],"demonstrated":[41],"superior":[42],"efficacy":[43],"dose":[48,61,103,116,184,286,325,335,354],"(vs":[49],"mg/kg),":[51],"manageable":[54],"safety":[55],"profile.":[56],"In":[57,349],"clinical":[58,119],"practice,":[59],"initial":[60,102,114,284,352],"reductions":[62],"may":[63],"occur":[64],"despite":[65],"absence":[67],"formal":[69],"guidelines,":[70],"often":[71],"as":[72,91],"precautionary":[74],"measure.":[75],"Furthermore,":[76],"fixed":[78],"200":[79],"mg":[80],"vial":[81],"size":[82],"presents":[83],"financial":[84],"constraints":[85],"within":[86],"Polish":[88],"reimbursement":[89,367],"system,":[90],"unutilized":[92],"drug":[93],"waste":[94],"not":[96,328,361],"accounted":[97],"for,":[98],"inadvertently":[99],"leading":[100],"to":[101,295,371],"modifications.":[104],"Methods:":[105],"This":[106],"retrospective":[107],"cohort":[108],"study":[109],"assessed":[110],"impact":[112,321],"SG":[115,285,353],"reduction":[117,185,326,355],"outcomes":[120],"tolerability":[122],"four":[124],"oncology":[125],"centers":[126],"Poland":[128],"(August":[129],"2021\u2013September":[130],"2024).":[131],"Data":[132],"from":[133],"medical":[134],"records":[135],"included":[136],"baseline":[137],"characteristics,":[138],"details,":[140],"survival":[141,188,192],"outcomes,":[142],"adverse":[144],"events":[145],"(AEs)":[146],"graded":[147],"per":[148],"Common":[149],"Terminology":[150],"Criteria":[151],"Adverse":[153],"Events":[154],"(CTCAE)":[155],"v5.0.":[156],"Survival":[157],"was":[158,198,226,238,268],"estimated":[159],"using":[160],"Kaplan-Meier":[162],"method,":[163],"intergroup":[165],"differences":[166],"were":[167,249],"analyzed":[168],"chi-square":[171],"test.":[172],"A":[173,194],"multivariate":[174],"Cox":[175],"proportional":[176],"hazards":[177],"model":[178],"evaluated":[179],"independent":[181],"effect":[182],"overall":[187],"(OS)":[189],"progression-free":[191],"(PFS).":[193],"p-value":[195],"<":[196,309],"0.05":[197],"considered":[199],"statistically":[200],"significant.":[201],"Results:":[202],"Among":[203],"83":[204],"patients":[205],"(median":[206,302],"age:":[207],"55":[208],"years;":[209],"interquartile":[210],"range":[211],"[IQR]:":[212],"30\u201386),":[213],"median":[216,224,236],"follow-up":[217],"7.5":[219],"months":[220,228,240],"(IQR:":[221],"3.22\u201311.29),":[222],"PFS":[225],"3.9":[227],"(95%":[229,241],"confidence":[230],"interval":[231],"[CI]:":[232],"2.77\u20134.55),":[233],"OS":[237,293,358],"8.0":[239],"CI:":[242,316],"6.38\u20139.83).":[243],"Grade":[244,337],"\u22653":[247,340],"AEs":[248],"observed":[250],"83.1%":[252],"(n":[253,258,272,287,299],"=":[254,259,273,288,300],"69)":[255],"56.6%":[257],"47)":[260],"patients,":[262],"respectively.":[263],"Granulocyte":[264],"colony-stimulating":[265],"factor":[266],"(G-CSF)":[267],"administered":[269],"84.3%":[271],"70)":[274],"cases.":[276],"Patients":[277],"who":[278],"received":[279],">":[280],"80%":[281],"74)":[289],"had":[290],"significantly":[291,329,356],"longer":[292],"compared":[294],"those":[296],"receiving":[297],"\u226480%":[298],"9)":[301],"OS:":[303],"8.43":[304],"vs.":[305],"2.8":[306],"months,":[307],"p":[308],"0.001,":[310],"hazard":[311],"ratio":[312],"[HR]:":[313],"4.826,":[314],"95%":[315],"2.06\u201311.30),":[317],"no":[319],"significant":[320],"PFS.":[323],"Initial":[324],"did":[327,360],"affect":[330],"toxicity":[332],"profile":[333],"(further":[334],"reductions,":[336],"or":[339,342],"AEs)":[341],"need":[344],"G-CSF":[346],"administration.":[347],"Conclusions:":[348],"our":[350],"study,":[351],"affected":[357],"but":[359],"improve":[362],"toxicity.":[363],"Further":[364],"research":[365],"adjustments":[368],"are":[369],"needed":[370],"support":[372],"appropriate":[373],"dosing.":[374]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}